Investing.com -- Serina Therapeutics Inc (NYSE:SER) stock surged 30.2% in after-hours trading Wednesday following FDA ...

Serina Therapeutics shares jumped nearly 35% after the FDA cleared its IND application for SER-252, advancing plans for a ...

From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...

Shares of Serina Therapeutics surged after an investigational new drug application for a Parkinson's disease treatment was approved by the Food and Drug Administration. The stock rose 35% to $3.67 in ...

Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program - HUNTSVILLE, AL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, ...

TRPML1 is a promising target1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement ...

According to Mr. Lee Ming-Juan, Vice General Manager of Shine Out Bio Technology, preclinical studies using <ALPHA>DAT-EVs loaded with curcumin have demonstrated promising therapeutic effects in both ...

Advanced Parkinson's disease patients in Calgary have had access since 2024 to a treatment called Vyalev, which an Edmonton ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.

New research reveals how Parkinson's spreads from the gut to the brain, with the help of immune cells—offering a new ...

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...